AAAAAA

   
Results: 1-7 |
Results: 7
The role of gonadotropin-releasing hormone antagonists in in vitro fertilization
Authors: Diedrich, K Ludwig, M Felberbaum, RE
Citation: K. Diedrich et al., The role of gonadotropin-releasing hormone antagonists in in vitro fertilization, SEMIN REP M, 19(3), 2001, pp. 213-220
Health of 227 children born after controlled ovarian stimulation for in vitro fertilization using the luteinizing hormone-releasing hormone antagonist cetrorelix
Authors: Ludwig, M Riethmuller-Winzen, H Felberbaum, RE Olivennes, F Albano, C Devroey, P Diedrich, K
Citation: M. Ludwig et al., Health of 227 children born after controlled ovarian stimulation for in vitro fertilization using the luteinizing hormone-releasing hormone antagonist cetrorelix, FERT STERIL, 75(1), 2001, pp. 18-22
Significant reduction of the incidence of ovarian hyperstimulation syndrome (OHSS) by using the LHRH antagonist Cetrorelix (Cetrotide (R)) in controlled ovarian stimulation for assisted reproduction
Authors: Ludwig, M Felberbaum, RE Devroey, P Albano, C Riethmuller-Winzen, H Schuler, A Engel, W Diedrich, K
Citation: M. Ludwig et al., Significant reduction of the incidence of ovarian hyperstimulation syndrome (OHSS) by using the LHRH antagonist Cetrorelix (Cetrotide (R)) in controlled ovarian stimulation for assisted reproduction, ARCH GYN OB, 264(1), 2000, pp. 29-32
Deep vein thrombosis during administration of HMG for ovarian stimulation
Authors: Ludwig, M Felberbaum, RE Diedrich, K
Citation: M. Ludwig et al., Deep vein thrombosis during administration of HMG for ovarian stimulation, ARCH GYN OB, 263(3), 2000, pp. 139-141
Ovarian stimulation far assisted reproduction with HMG and concomitant midcycle administration of the GnRH antagonist Cetrorelix according to the multiple dose protocol: a prospective uncontrolled phase III study
Authors: Felberbaum, RE Albano, C Ludwig, M Riethmuller-Winzen, H Grigat, M Devroey, P Diedrich, K
Citation: Re. Felberbaum et al., Ovarian stimulation far assisted reproduction with HMG and concomitant midcycle administration of the GnRH antagonist Cetrorelix according to the multiple dose protocol: a prospective uncontrolled phase III study, HUM REPR, 15(5), 2000, pp. 1015-1020
Ovarian stimulation with HMG: results of a prospective randomized phase III European study comparing the luteinizing hormone-releasing hormone (LHRH)-antagonist cetrorelix and the LHRH-agonist buserelin
Authors: Albano, C Felberbaum, RE Smitz, J Riethmuller-Winzen, H Engel, J Diedrich, K Devroey, P
Citation: C. Albano et al., Ovarian stimulation with HMG: results of a prospective randomized phase III European study comparing the luteinizing hormone-releasing hormone (LHRH)-antagonist cetrorelix and the LHRH-agonist buserelin, HUM REPR, 15(3), 2000, pp. 526-531
Ovarian abscess and heterotopic triplet pregnancy: two complications afterIVF in one patient
Authors: Ludwig, M Felberbaum, RE Bauer, O Diedrich, K
Citation: M. Ludwig et al., Ovarian abscess and heterotopic triplet pregnancy: two complications afterIVF in one patient, ARCH GYN OB, 263(1-2), 1999, pp. 25-28
Risultati: 1-7 |